Waypoint Capital Advisors, LLC
- SEC CIK
- 0001905662
- Latest filing
- Oct 18, 2024
ABT holding history
Abbott Laboratories in every 13F filed by Waypoint Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q3 2024 holdings
- Shares (Q3 2024)
- 6,886
- Value
- $785.1K
- % of portfolio
- 0.2%
- Quarters held
- 12
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 6,886 | $785.1K | 0.2% | +214+3.2% | Added | Holders |
| Q2 2024 | 6,672 | $693.3K | 0.2% | +58+0.9% | Added | Holders |
| Q1 2024 | 6,614 | $751.7K | 0.2% | +33+0.5% | Added | Holders |
| Q4 2023 | 6,581 | $724.4K | 0.2% | −126−1.9% | Reduced | Holders |
| Q3 2023 | 6,707 | $649.6K | 0.2% | +1,771+35.9% | Added | Holders |
| Q2 2023 | 4,936 | $538.1K | 0.2% | +47+1.0% | Added | Holders |
| Q1 2023 | 4,889 | $495.1K | 0.2% | −30−0.6% | Reduced | Holders |
| Q4 2022 | 4,919 | $540.1K | 0.2% | −484−9.0% | Reduced | Holders |
| Q3 2022 | 5,403 | $522.0K | 0.2% | −29−0.5% | Reduced | Holders |
| Q2 2022 | 5,432 | $590.0K | 0.3% | −95−1.7% | Reduced | Holders |
| Q1 2022 | 5,527 | $654.0K | 0.4% | +14+0.3% | Added | Holders |
| Q4 2021 | 5,513 | $776.0K | 0.5% | – | No prior filing | Holders |